KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Aug 17, 2025 | Option/RSU Exercise | - | 9,362 | - | 378,957 | Aug 19, 2025, 04:26 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Aug 18, 2025 | Sale | $13.19 | 4,409 | 58,141 | 374,548 | Aug 19, 2025, 04:26 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Jul 09, 2025 | Sale | $15.69 | 32,979 | 517,523 | 369,595 | Jul 10, 2025, 08:56 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Jun 06, 2025 | Option/RSU Exercise | - | 15,625 | - | 322,243 | Jun 10, 2025, 05:00 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Jun 09, 2025 | Sale | $14.50 | 7,169 | 103,951 | 315,074 | Jun 10, 2025, 05:00 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | May 21, 2025 | Option/RSU Exercise | - | 23,250 | - | 316,617 | May 23, 2025, 04:24 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | May 22, 2025 | Sale | $11.88 | 9,999 | 118,743 | 306,618 | May 23, 2025, 04:24 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | May 17, 2025 | Option/RSU Exercise | - | 9,364 | - | 297,175 | May 20, 2025, 07:28 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | May 19, 2025 | Sale | $11.84 | 3,808 | 45,097 | 293,367 | May 20, 2025, 07:28 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Mar 06, 2025 | Option/RSU Exercise | - | 15,625 | - | 294,480 | Mar 10, 2025, 06:43 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Mar 07, 2025 | Sale | $11.97 | 6,669 | 79,828 | 287,811 | Mar 10, 2025, 06:43 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Feb 17, 2025 | Option/RSU Exercise | - | 9,363 | - | 283,959 | Feb 19, 2025, 08:46 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Feb 18, 2025 | Sale | $9.82 | 5,104 | 50,143 | 278,855 | Feb 19, 2025, 08:46 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Dec 09, 2024 | Sale | $9.75 | 7,627 | 74,363 | 274,596 | Dec 09, 2024, 09:08 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Dec 06, 2024 | Option/RSU Exercise | - | 15,625 | - | 282,223 | Dec 09, 2024, 09:08 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Nov 17, 2024 | Option/RSU Exercise | - | 30,198 | - | 280,998 | Nov 19, 2024, 07:19 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Nov 18, 2024 | Sale | $9.26 | 14,400 | 133,294 | 266,598 | Nov 19, 2024, 07:19 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Sep 06, 2024 | Option/RSU Exercise | - | 15,625 | - | 258,152 | Sep 10, 2024, 08:31 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Sep 09, 2024 | Sale | $12.19 | 7,352 | 89,622 | 250,800 | Sep 10, 2024, 08:31 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Aug 17, 2024 | Option/RSU Exercise | - | 30,195 | - | 256,742 | Aug 21, 2024, 09:25 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Aug 19, 2024 | Sale | $12.01 | 14,215 | 170,769 | 242,527 | Aug 21, 2024, 09:25 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Jun 06, 2024 | Option/RSU Exercise | - | 15,625 | - | 232,012 | Jun 10, 2024, 06:42 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | Jun 07, 2024 | Sale | $11.53 | 7,465 | 86,068 | 224,547 | Jun 10, 2024, 06:42 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | May 17, 2024 | Option/RSU Exercise | - | 51,031 | - | 238,346 | May 21, 2024, 05:57 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | May 20, 2024 | Sale | $11.76 | 21,959 | 258,337 | 216,387 | May 21, 2024, 05:57 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO | Feb 17, 2024 | Option/RSU Exercise | - | 51,029 | - | 210,117 | Feb 21, 2024, 09:46 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO | Feb 20, 2024 | Sale | $14.11 | 22,802 | 321,846 | 187,315 | Feb 21, 2024, 09:46 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO | Feb 14, 2024 | Sale | $15.01 | 40,855 | 613,205 | 159,088 | Feb 16, 2024, 04:21 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | President, CFO, CBO & Sec'y | Nov 17, 2023 | Option/RSU Exercise | - | 30,197 | - | 125,451 | Nov 21, 2023, 04:31 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | President, CFO, CBO & Sec'y | Nov 20, 2023 | Sale | $8.23 | 13,008 | 107,047 | 112,443 | Nov 21, 2023, 04:31 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | President, CFO, CBO & Sec'y | Aug 17, 2023 | Option/RSU Exercise | - | 30,195 | - | 108,321 | Aug 21, 2023, 08:05 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | President, CFO, CBO & Sec'y | Aug 18, 2023 | Sale | $10.73 | 13,067 | 140,192 | 95,254 | Aug 21, 2023, 08:05 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | President, CFO, CBO & Sec'y | May 17, 2023 | Option/RSU Exercise | - | 9,364 | - | 82,163 | May 19, 2023, 09:19 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | President, CFO, CBO & Sec'y | May 18, 2023 | Sale | $10.14 | 4,037 | 40,953 | 78,126 | May 19, 2023, 09:19 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | President, CFO, CBO & Sec'y | Feb 17, 2023 | Sale | $7.66 | 4,954 | 37,948 | 72,799 | Feb 23, 2023, 05:41 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | President, CFO, CBO & Sec'y | Feb 17, 2023 | Option/RSU Exercise | - | 9,363 | - | 77,753 | Feb 23, 2023, 05:41 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO & Secretary | Nov 17, 2022 | Option/RSU Exercise | - | 2,419 | - | 69,112 | Nov 21, 2022, 04:20 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO & Secretary | Nov 18, 2022 | Sale | $5.44 | 722 | 3,928 | 68,390 | Nov 21, 2022, 04:20 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO & Secretary | Aug 17, 2022 | Option/RSU Exercise | - | 2,418 | - | 67,418 | Aug 19, 2022, 05:15 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO & Secretary | Aug 17, 2022 | Sale | $14.96 | 725 | 10,847 | 66,693 | Aug 19, 2022, 05:15 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO & Secretary | Feb 23, 2021 | Sale | $33.59 | 29,642 | 995,562 | 93,642 | Feb 25, 2021, 08:23 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO & Secretary | Feb 23, 2021 | Option/RSU Exercise | $6.74 | 29,642 | 199,787 | 94,642 | Feb 25, 2021, 08:23 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO & Secretary | Dec 30, 2020 | Option/RSU Exercise | $6.74 | 358 | 2,413 | 32,858 | Jan 04, 2021, 06:06 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CFO, CBO & Secretary | Dec 30, 2020 | Sale | $20.04 | 358 | 7,175 | 32,500 | Jan 04, 2021, 06:06 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CBO, CFO and Secretary | Apr 22, 2019 | Option/RSU Exercise | $8.39 | 2,000 | 16,780 | 34,500 | Apr 22, 2019, 05:58 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CBO, CFO and Secretary | Apr 22, 2019 | Sale | $25.80 | 2,000 | 51,603 | 32,500 | Apr 22, 2019, 05:58 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CBO, CFO and Secretary | Apr 18, 2019 | Option/RSU Exercise | $6.74 | 1,073 | 7,232 | 33,573 | Apr 22, 2019, 05:58 PM |
KALV | | KalVista Pharmaceuticals, Inc. | Benjamin L. Palleiko | CBO, CFO and Secretary | Apr 18, 2019 | Sale | $25.51 | 1,073 | 27,373 | 32,500 | Apr 22, 2019, 05:58 PM |